ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NAVB Navidea Biopharmaceuticals Inc

0.0779
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Navidea Biopharmaceuticals Inc AMEX:NAVB AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0779 0 01:00:00

Navidea Biopharmaceuticals to Announce Third Quarter 2015 Financial Results on November 4, 2015

26/10/2015 11:30am

Business Wire


Navidea Biopharmaceuticals (AMEX:NAVB)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Navidea Biopharmaceuticals Charts.

- Conference call with investment community to follow at 8:30 a.m. EST -

Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB) today announced that the Company will report its financial results for the third quarter 2015, on Wednesday, November 4, 2015 prior to a conference call with the investment community scheduled at 8:30 a.m. EST.

Investors and the public are invited to access the live audio webcast through the link below. Participants who would like to ask questions during the question and answer session must participate by telephone also. Participants are encouraged to log-in and/or dial-in fifteen minutes before the conference call begins. The webcast replay is expected to be available on our investor website, http://ir.navidea.com, approximately two to four hours after the live event.

Event:     Navidea Biopharmaceuticals Q3 2015 Financial Results Conference Call Date/Time:

Wednesday, November 4, 2015 at 8:30 a.m. EST

Webcast Link:

http://edge.media-server.com/m/p/apewz7w6/lan/en

Dial-in Number – US:

(855) 897-5884

Dial in Number – Int’l: (720) 634-2940 Conference ID Number: 64585280 Replay

A webcast replay will be available on the Investor Relations section of our website at http://ir.navidea.com for 30 days.

About Navidea

Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB) is a biopharmaceutical company focused on the development and commercialization of precision immuno-diagnostic agents and immuno-therapeutics. Navidea is developing multiple precision-targeted products and platforms including Manocept™ and NAV4694 to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Lymphoseek® (technetium Tc 99m tilmanocept) injection, Navidea’s first commercial product from the Manocept platform, was approved by the FDA in March 2013 and in Europe in November 2014. Navidea’s strategy is to deliver superior growth and shareholder return by bringing to market novel immuno-diagnostic agents and immuno-therapeutics, and advancing the Company’s pipeline through global partnering and commercialization efforts. For more information, please visit www.navidea.com.

Navidea BiopharmaceuticalsInvestorsTom Baker, 617-532-0624tbaker@navidea.comorMediaSharon Correia, 978-655-2686Associate Director, Corporate Communications

1 Year Navidea Biopharmaceuticals Chart

1 Year Navidea Biopharmaceuticals Chart

1 Month Navidea Biopharmaceuticals Chart

1 Month Navidea Biopharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock